JOHNSON & JOHNSON Investing Cash Flow 2007-2026 | JNJ
Beta
What is investing cash flow?
Investing cash flow represents cash used for or generated from investment activities, including capital expenditures, acquisitions, and investment purchases or sales.
What is JOHNSON & JOHNSON's current investing cash flow?
JOHNSON & JOHNSON (JNJ) annual investing cash flow for 2025 was $-23.59B, a 26.82% decline from 2024. JOHNSON & JOHNSON investing cash flow for the quarter ending March 29, 2026 was $-1.04B.
What was JOHNSON & JOHNSON's investing cash flow in 2024?
JOHNSON & JOHNSON annual investing cash flow for 2024 was $-18.60B, a 2218.34% decline from 2023.
What was JOHNSON & JOHNSON's investing cash flow in 2023?
JOHNSON & JOHNSON annual investing cash flow for 2023 was $878.0M, a 110.11% increase from 2022.
Investing Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGRN/A
FY2019
$-6.19B
→
FY2025
$-23.59B
07081011121314161718192122232425
5 years selected
Investing Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-23.59B | -26.8% | 10-K |
| FY2024 | $-18.60B | -2218.3% | 10-K |
| FY2023 | $878.0M | +110.1% | 10-K |
| FY2022 | $-8.68B | +58.3% | 10-K |
| FY2021 | $-20.82B | -236.2% | 10-K |
| FY2019 | $-6.19B | -95.6% | 10-K |
| FY2018 | $-3.17B | +78.7% | 10-K |
| FY2017 | $-14.87B | -92.2% | 10-K |
| FY2016 | $-7.74B | +37.1% | 10-K |
| FY2014 | $-12.30B | -141.1% | 10-K |
| FY2013 | $-5.10B | -13.1% | 10-K |
| FY2012 | $-4.51B | +42.6% | 10-K |
| FY2011 | $-7.85B | -3.4% | 10-K |
| FY2010 | $-7.60B | -81.5% | 10-K |
| FY2008 | $-4.19B | +29.2% | 10-K |
| FY2007 | $-5.91B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →